IDWeek 2023
Boston, Massachusetts 11 October 2023 - 15 October 2023
One BPG dose may be enough to treat syphilis, regardless of HIV status
26 Oct 2023
bởiJairia Dela Cruz
Three doses of benzathine penicillin G (BPG) are not necessarily better than a single dose in the treatment of early syphilis in individuals with or without HIV infection, as shown in a study.
One BPG dose may be enough to treat syphilis, regardless of HIV status
26 Oct 2023
Pooled EAGLE subgroup analyses boost gepotidacin potential for uUTI in females
25 Oct 2023
bởiAudrey Abella
In a pooled analyses of data from the EAGLE*-2 and EAGLE-3 studies, the investigational, first-in-class, oral, triazaacenaphthylene bactericidal antibiotic gepotidacin showed consistent therapeutic efficacy across key patient subgroups and had an acceptable safety profile in female adults and adolescents with uncomplicated urinary tract infections (uUTI) compared with nitrofurantoin.
